Biofilms in chronic rhinosinusitis: A review

American Journal of Rhinology and Allergy

Volumn 23, Issue 3, 2009, Pages 255-260

  Cohen, Michael ^a   Kofonow, Jennifer ^a   Nayak, Jaytakar V ^a   Palmer, James N ^a   Chiu, Alexander G ^a   Leid, Jeff G ^b   Cohen, Noam A ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NORTHERN ARIZONA UNIVERSITY   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Biofilm; Chronic; Cilia; MBEC; Mucociliary clearance; Mucosa; Pseudomonas; Rhinosinusitis; SNOT 22; UPSIT

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; CITRIC ACID ZWITTERIONIC SURFACTANT; FUROSEMIDE; GENTAMICIN; IONIC SURFACTANT; MOXIFLOXACIN; PIPERACILLIN; PSEUDOMONIC ACID; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM IDENTIFICATION; BIOFILM; CHRONIC DISEASE; CONFOCAL LASER MICROSCOPY; DISEASE COURSE; DRUG BLOOD LEVEL; ELECTRON MICROSCOPY; FLUORESCENCE IN SITU HYBRIDIZATION; HAEMOPHILUS INFLUENZAE; HEARING LOSS; HUMAN; MICROBIAL COMMUNITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NOSE MUCOSA; PSEUDOMONAS AERUGINOSA; REVIEW; RHINOSINUSITIS; SCANNING ELECTRON MICROSCOPY; STREPTOCOCCUS PNEUMONIAE; TRANSMISSION ELECTRON MICROSCOPY; VERTIGO; ANIMAL; BACTERIUM; ISOLATION AND PURIFICATION; MICROBIOLOGY; RHINITIS; SINUSITIS;

ANIMALS; BACTERIA; BIOFILMS; CHRONIC DISEASE; HUMANS; RHINITIS; SINUSITIS;

EID: 67849122623     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2009.23.3319     Document Type: Review

References (45)

1. Blackwell D, Collins J, and Coles R. Summary health statistics for U.S. adults: National Health Interview Survey, 1997. National Center for Health Statistics. Vital Health Stat 10:15, 2002.
2. Cherry DK, and Woodwell DA. National Ambulatory Medical Care Survey: 2000 Summary. Adv Data 328:1-32, 2002.
3. Ly N, and McCaig LF. National Hospital Ambulatory Medical Care Survey: 2000 Outpatient department summary. Adv Data 327:1-27, 2002.
4. Ray NF, Baraniuk JN, Thamer M, et al. Healthcare expenditures for sinusitis in 1996: Contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 103:408-414, 1999.
5. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 129:S1-S32, 2003.
6. Gliklich RE, and Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg 113:104-109, 1995.
7. Khalid AN, Quraishi SA, and Kennedy DW. Long-term quality of life measures after functional endoscopic sinus surgery. Am J Rhinol 18:131-136, 2004.
8. Ramadan HH, Sanclement JA, and Thomas JG. Chronic rhinosinusitis and biofilms. Otolaryngol Head Neck Surg 132:414-417, 2005.
9. Bendouah Z, Barbeau J, Hamad WA, and Desrosiers M. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 134:991-996, 2006.
10. Ferguson BJ, and Stolz DB. Demonstration of biofilm in human bacterial chronic rhinosinusitis. Am J Rhinol 19:452-457, 2005.
11. Perloff JR, and Palmer JN. Evidence of bacterial biofilms on frontal recess stents in patients with chronic rhinosinusitis. Am J Rhinol 18:377-380, 2004.
12. Sanclement JA, Webster P, Thomas J, and Ramadan HH. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 115:578-582, 2005.
13. Palmer J. Bacterial biofilms in chronic rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 196:35-39, 2006.
14. Costerton JW, Stewart PS, and Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 284: 1318-1322, 1999.
15. Palmer JN. Bacterial biofilms: Do they play a role in chronic sinusitis? Otolaryngol Clin North Am 38:1193-11201, viii, 2005.
16. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5:48-56, 2007.
17. Fux CA, Costerton JW, Stewart PS, and Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 13:34-40, 2005.
18. Stewart PS, and Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138, 2001.
19. Ha KR, Psaltis AJ, Tan L, and Wormald PJ. A sheep model for the study of biofilms in rhinosinusitis. Am J Rhinol 21:339-345, 2007.
20. Sanderson AR, Leid JG, and Hunsaker D. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope 116:1121-1126, 2006.
21. Healy DY, Leid JG, Sanderson AR, and Hunsaker DH. Biofilms with fungi in chronic rhinosinusitis. Otolaryngol Head Neck Surg 138:641-647, 2008.
22. Moskowitz SM, Foster JM, Emerson J, and Burns JL. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 42:1915-1922, 2004.
23. Prince AA, Steiger JD, Khalid AN, et al. Prevalence of biofilm-forming bacteria in chronic rhinosinusitis. Am J Rhinol 22:239-245, 2008.
24. Post JC. Direct evidence of bacterial biofilms in otitis media. Laryngoscope 111:2083-2094, 2001.
25. Perloff JR, and Palmer JN. Evidence of bacterial biofilms in a rabbit model of sinusitis. Am J Rhinol 19:1-6, 2005.
26. Psaltis AJ, Ha KR, Beule AG, et al. Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis. Laryngoscope 117:1302-1306, 2007.
27. Zuliani G, Carron M, Gurrola J, et al. Identification of adenoid biofilms in chronic rhinosinusitis. Int J Pediatr Otorhinolaryngol 70:1613-1617, 2006.
28. Gates GA. Adenoidectomy for otitis media with effusion. Ann Otol Rhinol Laryngol Suppl 163:54-58, 1994.
29. Maw AR. Age and adenoid size in relation to adenoidectomy in otitis media with effusion.AmJ Otolaryngol 6:245-248, 1985.
30. Desrosiers M, Bendouah Z, and Barbeau J. Effectiveness of topical antibiotics on Staphylococcus aureus biofilm in vitro. Am J Rhinol 21:149-153, 2007.
31. Ceri H, et al. The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37:1771-1776, 1999.
32. Chiu AG, Antunes MB, Palmer JN, and Cohen NA. Evaluation of the in vivo efficacy of topical tobramycin against Pseudomonas sinonasal biofilms. J Antimicrob Chemother 59:1130-1134, 2007.
33. Whatley WS, Chandra RK, and MacDonald CB. Systemic absorption of gentamicin nasal irrigations. Am J Rhinol 20: 251-254, 2006.
34. Ha KR, Psaltis AJ, Butcher AR, et al. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope 118:535-540, 2008.
35. Sutherland R, Boon RJ, Griffon KE, et al. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother 27:495-498, 1985.
36. Hill RL. The bioavailability of mupirocin in nasal secretions in vitro. J Clin Pathol 55:233-235, 2002.
37. Solares CA, Batra PS, Hall GS, and Citardi MJ. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations. Am J Otolaryngol 27:161-165, 2006.
38. Uren B, Psaltis A, and Wormald PJ. Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis. Laryngoscope 118:1677-1680, 2008.
39. Chiu AG, Palmer JN, Woodworth BA, et al. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol 22:34-37, 2008.
40. Cross JL, Ramadan HH, and Thomas JG. The impact of a cation channel blocker (furosemide) on Pseudomonas aeruginosa PAO1 biofilm architecture. Otolaryngol Head Neck Surg 137:21-26, 2007.
41. Desrosiers M, Myntti M, and James G. Methods for removing bacterial biofilms: In vitro study using clinical chronic rhinosinusitis specimens. Am J Rhinol 21:527-532, 2007.
42. Wormald PJ, Psaltis A, and Ba Le T. The investigation of several anit-biofilm treatments using an in-vivo animal model. In Conference of the American Rhinologic Society 27-28 (Orlando, FL, 2008).
43. Cohen NA, Tamashiro E, Antunes MB, and Chiu AG. In vivo effects of citric acid/zwitterionic surfactant (CAZS) cleansing solution on sinus mucosa. In Conference of the American Rhinologic Society 44-45 (Orlando, FL, 2008).
44. Cryer J, Schipor I, Perloff JR, and Palmer JN. Evidence of bacterial biofilms in human chronic sinusitis. ORL J Otorhinolaryngol Relat Spec 66:155-158, 2004.
45. Psaltis AJ, Weitzel EK, Ha KR, and Wormald PJ. The effect of bacterial biofilms on post-sinus surgical outcomes. Am J Rhinol 22:1-6, 2008.